Dabigatran

Key points

• Dabigatran may be used for selected people with Atrial Fibrillation or Venous Thromboembolism.
• The capsules must be stored and taken according to the exact product instructions; opening or altering them can change exposure.
• Do not stop dabigatran or interrupt it for a procedure without a clinician’s plan because clot risk can return quickly.

Listings are for comparison and general information, not an anticoagulation plan; suitability and supply depend on clinician and pharmacy checks, kidney function, indication and prescription requirements.

How dabigatran works

Dabigatran directly blocks thrombin, reducing the formation of fibrin that stabilises blood clots. This lowers harmful clot risk while increasing susceptibility to bleeding.

Clinically meaningful forms

Dabigatran capsules have moisture-sensitive packaging and product-specific handling requirements. They should not be treated like an ordinary tablet or transferred to another container unless the product information explicitly allows it.

Important safety checks

Kidney function, age, bleeding history, pregnancy, recent surgery and all medicines should be reviewed. Antiplatelets, anti-inflammatory painkillers and medicines that affect dabigatran transport can increase bleeding or change exposure. Tell every treating clinician and dentist before a procedure.

When to seek urgent care

Seek urgent help for uncontrolled bleeding, vomiting blood, black stools, red or brown urine, sudden severe headache, fainting, marked weakness or significant head injury. Sudden chest pain, breathlessness, one-sided weakness or speech difficulty may indicate a clot and is an emergency.

Further reading

• Dabigatran: MedlinePlus Drug Information
• Dabigatran Etexilate 110 mg hard capsules - Summary of Product Characteristics (SmPC) - (emc) | 15808
• Atrial Fibrillation